Tumor biology and careful patient selection weigh heavily in determining the appropriate role of surgical resection in stage IV melanoma. Historically, surgical resection for highly selected patients with metastatic melanoma was the only treatment modality associated with improved long-term survival and the ability to provide palliation. With the new age of effective systemic therapies, the treatment of metastatic melanoma has become more intricate and future work is needed to better define the role for surgery within the current treatment paradigm.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/jso.25326 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!